Stericycle (SRCL) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SRCL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRCL, but not buy additional shares or sell existing shares.
View SRCL analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 12 month price targets for Stericycle's shares. Their SRCL share price forecasts range from $45.00 to $70.00. On average, they expect the company's share price to reach $56.00 in the next twelve months. This suggests a possible upside of 28.6% from the stock's current price.
View analysts price targets for SRCL or view top-rated stocks among Wall Street analysts.

Stericycle's stock was trading at $49.89 at the start of the year. Since then, SRCL stock has decreased by 12.7% and is now trading at $43.56.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our SRCL earnings forecast.

Stericycle, Inc. (NASDAQ:SRCL) posted its earnings results on Thursday, July, 27th. The business services provider reported $0.43 EPS for the quarter, missing analysts' consensus estimates of $0.49 by $0.06. The business services provider earned $669.50 million during the quarter, compared to the consensus estimate of $683.48 million. Stericycle had a trailing twelve-month return on equity of 8.31% and a net margin of 0.79%. Stericycle's revenue was down 1.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.48 earnings per share.

ETFs with the largest weight of Stericycle (NASDAQ:SRCL) stock in their portfolio include VanEck Environmental Services ETF (EVX), iShares Environmental Infrastructure and Industrials ETF (EFRA), Ecofin U.S. Renewables Infrastructure Trust (RNEW), VanEck Morningstar SMID Moat ETF (SMOT), Schwab Ariel ESG ETF (SAEF), Qraft AI-Enhanced Next Value ETF (NVQ), Hypatia Women Ceo ETF (WCEO) and First Trust Utilities AlphaDEX Fund (FXU).

Stericycle issued an update on its FY 2023 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $1.75-$2.05 for the period, compared to the consensus estimate of $1.94. The company issued revenue guidance of -.

132 employees have rated Stericycle Chief Executive Officer Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRCL stock can currently be purchased for approximately $43.56.

Stericycle (NASDAQ:SRCL) has a market capitalization of $4.03 billion and generates $2.70 billion in revenue each year. The business services provider earns $56 million in net income (profit) each year or $0.23 on an earnings per share basis.

The company employs 15,000 workers across the globe.

Stericycle's mailing address is 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015. The official website for the company is www.stericycle.com. The business services provider can be reached via phone at (847) 367-5910, via email at investor@stericycle.com, or via fax at 847-367-9493.